Synergy Pharmaceuticals (NASDAQ: SGYP ) ("Synergy") today announced that it convened its annual meeting of stockholders yesterday and it has received the necessary approvals from its stockholders to authorize Synergy's merger with Callisto Pharmaceuticals (NASDAQ: CLSP ) pursuant to the previously announced Agreement and Plan of Merger, dated